BioSpace News Archive

Business

Provention Bio Appoints Jason Hoitt as Chief Commercial Officer

Provention Bio, Inc. announced the appointment of Jason Hoitt as Chief Commercial Officer.

January 8, 2020
·
4 min read
Business

Schrödinger and Bayer Collaborate to Co-Develop de novo Design Technology to Accelerate Drug Discovery

Schrödinger and Bayer (BAYN: DE) today announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative high-quality drugs.

January 8, 2020
·
3 min read
Biotech Bay

Veeva Introduces New Application to Speed Payments to Clinical Research Sites

Vault Payments enables sponsors and CROs to automatically create, track, and report payments in Vault CTMS for greater accuracy and visibility

January 8, 2020
·
4 min read
Drug Development

CStone announces first patient dosed in the Phase III trial of CS1001 in combination with chemotherapy in first-line esophageal squamous cell carcinoma

CStone Pharmaceuticals announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Company’s anti-PD-L1 antibody CS1001 in combination therapy as first-line treatment in patients with advanced esophageal squamous cell carcinoma.

January 8, 2020
·
5 min read
Drug Development

Promethera® Announces Initiation of Phase 2b DHELIVER Study of HepaStem™ in Patients with Acute-on-Chronic Liver Failure (ACLF)

Potentially pivotal trial for industry’s most-advanced cell-based therapy in severe liver diseases expected to generate results in H2 2023

January 8, 2020
·
4 min read
Business

Martin Jönsson Appointed New CEO of AlzeCure Pharma

AlzeCure Pharma AB, a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, announced that the board has appointed Martin Jönsson as new CEO.

January 8, 2020
·
3 min read
Pharm Country

OraSure Technologies to Present at the 38th Annual J.P. Morgan Healthcare Conference

OraSure Technologies, Inc., a leader in point of care diagnostic tests and specimen collection devices, announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 38TH Annual J.P. Morgan Healthcare Conference.

January 8, 2020
·
1 min read
Deals

Bright Health to Expand into California through Planned Acquisition of Brand New Day Health Plan

Bright Health, a diversified consumer-focused healthcare company, announced it has signed an agreement to acquire California-based Universal Care health plan.

January 8, 2020
·
3 min read
Deals

Avivagen Inc. Commences Trading on the OTCQB® Venture Market in the U.S.

Avivagen Inc., a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is pleased to announce that it has qualified to trade its common shares in the United States on the OTCQB® Venture Market.

January 8, 2020
·
4 min read
Genetown

Microbot Medical Receives Intention to Grant from European Patent Office for a Patent Application Covering its Self-Cleaning Shunt

Microbot Medical Inc. has received an official communication from the European Patent Office regarding its intention to grant European Patent Application No. 11795301, covering the Company’s Self-Cleaning Shunt.

January 8, 2020
·
3 min read